Developer docs
API playgroundTry for free, no card

Search company profiles

Rhia Ventures

Full company profile

uuid0000kwl

Namestring
Rhia Ventures
Legal namestring
Rhia Ventures
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Rhia Ventures is a 501(c)(3) nonprofit organization founded in 2018 and headquartered in San Francisco, CA, that advances reproductive and maternal health equity by leveraging capital markets. The organization operates through three interlocking activity areas: systems change (proprietary equity frameworks such as the HEART Framework and The REAL Framework), capital strategies (historically through RH Capital, an early-stage women's health venture fund that reached $43.5M in AUM across two funds before the investment team spun out as Foreground Capital in October 2024), and advising services to institutional investors, asset owners, and corporate employers on integrating health equity and racial equity into investment and benefits decisions.

Its core proprietary technology consists of frameworks rather than software: the HEART Framework (Health Equity Assessment and Rating Tool) for organizational positioning on health equity, Due Diligence 2.0 (a nine-shift framework for allocators to address systemic racial barriers in diligence, transferred from Adasina in November 2024), and The REAL Framework. Rhia also maintains narrative-change and accountability products including the P.S. Blossom podcast, the #WhatAreYourReproBenefits corporate-responses database, and a coordinated shareholder-advocacy program that has driven shareholder proposals receiving 30-47% average vote support.

The business model combines tax-deductible donations, paid advisory services, and, since 2025, priced cohort programs (the Impact Measurement & Management for Health Equity 2025 Cohort at $15,000 per organization, partnered with Impact Frontiers and Duke CASE). Customer segments are enterprise in nature: institutional investors and asset owners (foundations, endowments, family offices), corporate employers seeking post-Dobbs reproductive-health benefits guidance, and — historically via RH Capital — early-stage women's health startups. The 11-50 employee organization reported approximately $43.5M in cumulative capital deployed across its two funds prior to the Foreground Capital spin-out, with 20+ portfolio companies, and currently operates with no disclosed revenue figures.

Short descriptiontext

Rhia Ventures is a 501(c)(3) nonprofit founded in 2018 that advances reproductive and maternal health equity by equipping institutional investors, corporate employers, and women's health startups with proprietary equity-assessment frameworks (HEART, REAL, Due Diligence 2.0), shareholder advocacy, and venture capital deployment.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBellerose, United States
HQ citystring
Bellerose
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
impact venture capital, reproductive health equity, health equity frameworks, shareholder advocacy services, women's health investing
Industry2 codes
1Accelerators & Incubators (Investor-Operated)
CodeFSANAAAMPrimaryYes
2Philanthropy & Foundations Advisory (Donor-Advised Funds, Endowments)
CodeFSAAABAHPrimaryNo
NAICS code1 code
  • Other Financial Vehicles525990
SIC code1 code
  • Investment Advice6282
Product category
Reproductive Health Advocacy and Impact Investing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Donations and Charitable Contributions
TypeAffiliate Referral
Description

As a 501(c)(3) tax-exempt organization, Rhia Ventures receives donations from individuals, foundations, and organizations. Donations are tax-deductible as allowed by law. Tax ID number: 83-0828013.

rhiaventures.org
2Investment Returns (RH Capital)
TypeManaged Services
Description

RH Capital, a Rhia Ventures fund, is an impact-first venture capital fund that invests in early-stage startups in women's health. Returns from RH Capital fund investments support Rhia Ventures' operations.

rhiaventures.org
3Advisory Services
TypeProfessional Services
Description

Rhia Ventures provides advising services to organizations, investors, and entrepreneurs on incorporating health equity and racial equity into their capital strategy.

rhiaventures.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Others, Technology or R&D
Pricing details1 tier
1Impact Measurement & Management for Health Equity 2025 Cohort
ModelSubscriptionBilling cadenceAnnual
Notes

$15,000 per organization (up to 5 participants). Includes 6-month program with monthly sessions, guided DIY implementation (4 hours per month), 2 individual consulting sessions with Rhia Ventures Ecosystem Building team. Scholarships available for smaller teams and non-profit organizations.

rhiaventures.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1P.S. Blossom
Description

A podcast that connects the lived experiences of Black, Indigenous and other women of color to the innovations, policies, and narratives being created in the health and wellness market.

rhiaventures.org
+2 more records
Core offering1 text field

Rhia Ventures is a 501(c)(3) nonprofit that advances reproductive and maternal health equity through three activity pillars: systems change (proprietary equity frameworks such as HEART and The REAL), capital strategies (the RH Capital early-stage women's health venture fund), and advisory services for institutional investors, corporations, and entrepreneurs. The organization coordinates shareholder advocacy, operates educational learning cohorts, and accepts tax-deductible donations to support its mission.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Shareholder proposals on reproductive health filed by coordinated investors
+2 more records
Product overview1 text field

Rhia Ventures is a social impact nonprofit organization (501(c)(3)) that advances reproductive and maternal health equity by leveraging capital markets. The organization operates through three main activity areas: systems change (HEART Framework, The REAL), capital strategies (RH Capital venture fund), and advising services. Key products include RH Capital (early-stage women's health VC fund), the HEART Framework (health equity assessment tool), The REAL (racial equity in investment framework), P.S. Blossom podcast (narrative change), the #WhatAreYourReproBenefits database, and shareholder advocacy/coordinated proposals. The organization also runs educational programs like the Impact Measurement & Management for Health Equity cohort.

Product and service9 records
1RH Capital
CategoryVenture Capital Fund
Description

Impact-first venture capital fund that invests in early-stage startups promising to revolutionize women's health and improve health equity in the US; managed $43.5 million AUM across two funds with 20+ portfolio companies.

2HEART Framework
CategoryEquity Assessment Framework
Description

Health Equity Assessment and Rating Tool adapted from the REAL Framework, providing a standardized approach for organizations to assess their health equity positioning; includes Investor Framework, Diligence Tool, and Rating Tools.

3The REAL (Racial Equity Asset Lab)
CategoryEquity Investment Program
Description

Program that works with asset owners seeking to bring racial and gender equity to their investment decision-making; provides advising services and field-building activities including The REAL Framework, Due Diligence 2.0, Innovative Investors Toolkit, and Transparency Dashboard.

4Due Diligence 2.0 (DD2.0)
CategoryInvestment Due Diligence Framework
Description

Inclusive due diligence process designed to expand the aperture for investment opportunities and remove systemic barriers to underrepresented asset managers of color; includes nine shifts allocators can make in the due diligence process; has attracted 100+ signers.

5P.S. Blossom Podcast
CategoryNarrative Change Program
Description

Podcast that connects lived experiences of Black, Indigenous and other women of color to innovations, policies, and narratives in the health and wellness market; accompanied by SHIFT guides for narrative change.

6#WhatAreYourReproBenefits Database
CategoryCorporate Tracking Database
Description

Online database tracking corporate responses to abortion bans, covering communications affirming abortion access, policies covering abortion-related travel, paid time off for abortion travel, and support for reproductive health organizations.

7Impact Measurement & Management for Health Equity Cohort
CategoryEducational Cohort Program
Description

6-month paid learning cohort ($15,000 per organization, up to 5 participants) designed to help health-focused investors develop comprehensive impact management approaches; includes monthly sessions, guided DIY implementation, and individual consulting sessions.

8Charitable Donations Program
CategoryCharitable Giving Program
Description

501(c)(3) tax-exempt donation program accepting contributions from individuals, foundations, and organizations to advance reproductive and maternal health equity through capital deployment.

9Shareholder Advocacy Services
CategoryCorporate Engagement Services
Description

Coordinated shareholder advocacy services addressing reproductive health care access, data privacy, political spending alignment, and risk mitigation at corporations; engages institutional investors to file shareholder proposals.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-05-05
Description

Impact Frontiers partnered with Rhia Ventures and Duke University's CASE to offer the Impact Measurement and Management for Health Equity 2025 Cohort program for health-focused investors.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-05-05
Description

Duke University's CASE (Fuqua School of Business) partners with Rhia Ventures and Impact Frontiers to offer the Impact Measurement and Management for Health Equity 2025 Cohort.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-13
Description

Adasina Social Capital launched Due Diligence 2.0 Commitment in 2020 and is transferring ownership to Rhia Ventures' Racial Equity Asset Lab (The REAL). Partnership aims to bring innovation to asset management industry standards for risk assessment.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-01-21
Description

FSG is a social impact consulting firm that partnered with Rhia Ventures to publish Hidden Value: The Business Case for Reproductive Health, conducting research with PerryUndem surveying attitudes of 1,377 college-educated employed Americans.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

NMSC and Rhia Ventures co-hosted a program discussing NMSC's white paper on narrowing the Black-White health gap and opportunities for private investment to drive progress.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rhia Ventures partnered with Propelevate and Catalyst Global on a two-part virtual Masterclass for reproductive and maternal health companies looking to enter diverse global markets.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rhia Ventures partnered with Propelevate and Catalyst Global on masterclasses for reproductive and maternal health companies on scaling in diverse global contexts and navigating regulatory pathways.

8HealthTech4Medicaid (HT4M)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rhia Ventures partnered with HealthTech4Medicaid and Manatt Health to equip early and growth-stage companies to expand participation in the Medicaid market for reproductive and maternal health equity.

rhiaventures.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnered with Rhia Ventures and HealthTech4Medicaid to provide learning collaborative for reproductive and maternal health innovators on Medicaid market entry and expansion.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rhia Ventures hosted a virtual masterclass on Data Privacy for Reproductive Health with panelists from CDT, Euki, and aboboTech, providing practical strategies for funders and organizational leaders.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research partner conducting surveys on attitudes and opinions of Americans regarding reproductive health care. Research undergirds Hidden Value report published by Rhia Ventures.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1FSG
TypeDirect peer
Description

Social impact consulting firm that partnered with Rhia Ventures on the Hidden Value report. Operates at the intersection of impact strategy, foundation advising, and field-building in health equity.

TypeDirect peer
Description

Venture investing platform with a dedicated Femtech and women's health fund. Directly comparable as a women's health VC with similar stage and mission focus.

TypeDirect peer
Description

Co-founder and financial anchor of Rhia Ventures; a health-focused foundation that invests in reproductive and maternal health. Operates as a strategic philanthropic partner with overlapping program areas.

TypeDirect peer
Description

Independent venture firm spun out of RH Capital in September 2024, continuing to manage RH Capital Funds I and II and investing in early-stage women's health startups. Direct continuation of Rhia's VC investing activity.

TypeOthers
Description

Research partner that conducted the polling underpinning Rhia's Hidden Value report. Comparable as a reproductive health research and communications consultancy serving similar advocacy audiences.

TypeBroad incumbent
Description

Large women's rights foundation supporting reproductive justice and women's health movements. Operates broader than Rhia but is a comparable philanthropic and field-building player with overlapping grantee networks.

TypeEmerging player
Description

Mission-driven fund focused on women's health and wellness startups. Smaller and earlier-stage than Rhia's VC operations, but addresses the same thesis.

TypeDirect peer
Description

Venture capital firm investing in women's health innovation, similar to RH Capital's strategy. Comparable early-stage investor targeting the same underserved women's health category.

TypeDirect peer
Description

Social justice investment advisor that originated the Due Diligence 2.0 Commitment and transferred ownership to Rhia Ventures in 2024. Operates in the adjacent racial and gender equity investing space and shares frameworks for inclusive due diligence.

TypeDirect peer
Description

Collaborative of investors advancing impact management practice; co-delivers the Impact Measurement & Management for Health Equity cohort with Rhia Ventures and Duke CASE. Strongly overlapping audience of health-focused institutional investors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment15 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rhia Ventures

Reproductive Health Advocacy and Impact Investingrhiaventures.org

Rhia Ventures is a 501(c)(3) nonprofit founded in 2018 that advances reproductive and maternal health equity by equipping institutional investors, corporate employers, and women's health startups with proprietary equity-assessment frameworks (HEART, REAL, Due Diligence 2.0), shareholder advocacy, and venture capital deployment.

What Rhia Ventures does

Rhia Ventures is a 501(c)(3) nonprofit organization founded in 2018 and headquartered in San Francisco, CA, that advances reproductive and maternal health equity by leveraging capital markets. The organization operates through three interlocking activity areas: systems change (proprietary equity frameworks such as the HEART Framework and The REAL Framework), capital strategies (historically through RH Capital, an early-stage women's health venture fund that reached $43.5M in AUM across two funds before the investment team spun out as Foreground Capital in October 2024), and advising services to institutional investors, asset owners, and corporate employers on integrating health equity and racial equity into investment and benefits decisions.

Its core proprietary technology consists of frameworks rather than software: the HEART Framework (Health Equity Assessment and Rating Tool) for organizational positioning on health equity, Due Diligence 2.0 (a nine-shift framework for allocators to address systemic racial barriers in diligence, transferred from Adasina in November 2024), and The REAL Framework. Rhia also maintains narrative-change and accountability products including the P.S. Blossom podcast, the #WhatAreYourReproBenefits corporate-responses database, and a coordinated shareholder-advocacy program that has driven shareholder proposals receiving 30-47% average vote support.

The business model combines tax-deductible donations, paid advisory services, and, since 2025, priced cohort programs (the Impact Measurement & Management for Health Equity 2025 Cohort at $15,000 per organization, partnered with Impact Frontiers and Duke CASE). Customer segments are enterprise in nature: institutional investors and asset owners (foundations, endowments, family offices), corporate employers seeking post-Dobbs reproductive-health benefits guidance, and — historically via RH Capital — early-stage women's health startups. The 11-50 employee organization reported approximately $43.5M in cumulative capital deployed across its two funds prior to the Foreground Capital spin-out, with 20+ portfolio companies, and currently operates with no disclosed revenue figures.

Rhia Ventures firmographics

Firmographics
Name
Rhia Ventures
Legal name
Rhia Ventures
Website
https://rhiaventures.org
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Rhia Ventures is a 501(c)(3) nonprofit founded in 2018 that advances reproductive and maternal health equity by equipping institutional investors, corporate employers, and women's health startups with proprietary equity-assessment frameworks (HEART, REAL, Due Diligence 2.0), shareholder advocacy, and venture capital deployment.
Ownership category
akta.pro rank

Rhia Ventures industry classification

Industry
Product category
Reproductive Health Advocacy and Impact Investing
NAICS
Other Financial Vehicles (525990)
SIC
Investment Advice (6282)
akta.pro primary industry
Accelerators & Incubators (Investor-Operated) (FSANAAAM)
akta.pro secondary industry
Philanthropy & Foundations Advisory (Donor-Advised Funds, Endowments) (FSAAABAH)

Keywords

  • Impact venture capital
  • Reproductive health equity
  • Health equity frameworks
  • Shareholder advocacy services
  • Women's health investing

Where Rhia Ventures is headquartered

Location

Headquarters

HQ city
Bellerose
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rhia Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

  1. Donations and Charitable Contributions: As a 501(c)(3) tax-exempt organization, Rhia Ventures receives donations from individuals, foundations, and organizations. Donations are tax-deductible as allowed by law. Tax ID number: 83-0828013.
  2. Investment Returns (RH Capital): RH Capital, a Rhia Ventures fund, is an impact-first venture capital fund that invests in early-stage startups in women's health. Returns from RH Capital fund investments support Rhia Ventures' operations.
  3. Advisory Services: Rhia Ventures provides advising services to organizations, investors, and entrepreneurs on incorporating health equity and racial equity into their capital strategy.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualImpact Measurement & Management for Health Equity 2025 Cohort

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Rhia Ventures product offering

Product offering

Core offering

Rhia Ventures is a 501(c)(3) nonprofit that advances reproductive and maternal health equity through three activity pillars: systems change (proprietary equity frameworks such as HEART and The REAL), capital strategies (the RH Capital early-stage women's health venture fund), and advisory services for institutional investors, corporations, and entrepreneurs. The organization coordinates shareholder advocacy, operates educational learning cohorts, and accepts tax-deductible donations to support its mission.

Product overview

Rhia Ventures is a social impact nonprofit organization (501(c)(3)) that advances reproductive and maternal health equity by leveraging capital markets. The organization operates through three main activity areas: systems change (HEART Framework, The REAL), capital strategies (RH Capital venture fund), and advising services. Key products include RH Capital (early-stage women's health VC fund), the HEART Framework (health equity assessment tool), The REAL (racial equity in investment framework), P.S. Blossom podcast (narrative change), the #WhatAreYourReproBenefits database, and shareholder advocacy/coordinated proposals. The organization also runs educational programs like the Impact Measurement & Management for Health Equity cohort.

Differentiator

Problem solved

Functional benefit

Brands

  • P.S. Blossom: A podcast that connects the lived experiences of Black, Indigenous and other women of color to the innovations, policies, and narratives being created in the health and wellness market.
  • HEART Framework
  • #WhatAreYourReproBenefits

Products and services

  • RH Capital Impact-first venture capital fund that invests in early-stage startups promising to revolutionize women's health and improve health equity in the US; managed $43.5 million AUM across two funds with 20+ portfolio companies.
  • HEART Framework Health Equity Assessment and Rating Tool adapted from the REAL Framework, providing a standardized approach for organizations to assess their health equity positioning; includes Investor Framework, Diligence Tool, and Rating Tools.
  • The REAL (Racial Equity Asset Lab) Program that works with asset owners seeking to bring racial and gender equity to their investment decision-making; provides advising services and field-building activities including The REAL Framework, Due Diligence 2.0, Innovative Investors Toolkit, and Transparency Dashboard.
  • Due Diligence 2.0 (DD2.0) Inclusive due diligence process designed to expand the aperture for investment opportunities and remove systemic barriers to underrepresented asset managers of color; includes nine shifts allocators can make in the due diligence process; has attracted 100+ signers.
  • P.S. Blossom Podcast Podcast that connects lived experiences of Black, Indigenous and other women of color to innovations, policies, and narratives in the health and wellness market; accompanied by SHIFT guides for narrative change.
  • #WhatAreYourReproBenefits Database Online database tracking corporate responses to abortion bans, covering communications affirming abortion access, policies covering abortion-related travel, paid time off for abortion travel, and support for reproductive health organizations.
  • Impact Measurement & Management for Health Equity Cohort 6-month paid learning cohort ($15,000 per organization, up to 5 participants) designed to help health-focused investors develop comprehensive impact management approaches; includes monthly sessions, guided DIY implementation, and individual consulting sessions.
  • Charitable Donations Program 501(c)(3) tax-exempt donation program accepting contributions from individuals, foundations, and organizations to advance reproductive and maternal health equity through capital deployment.
  • Shareholder Advocacy Services Coordinated shareholder advocacy services addressing reproductive health care access, data privacy, political spending alignment, and risk mitigation at corporations; engages institutional investors to file shareholder proposals.

Quantifiable outcome

  • Shareholder proposals on reproductive health filed by coordinated investors
  • +2 more outcomes

Companies that use Rhia Ventures

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Rhia Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Rhia Ventures partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered minor and core.

  • Impact FrontiersminorStrategic or Co-development Partner · 5 May 2025Impact Frontiers partnered with Rhia Ventures and Duke University's CASE to offer the Impact Measurement and Management for Health Equity 2025 Cohort program for health-focused investors.
  • Duke University CASEminorStrategic or Co-development Partner · 5 May 2025Duke University's CASE (Fuqua School of Business) partners with Rhia Ventures and Impact Frontiers to offer the Impact Measurement and Management for Health Equity 2025 Cohort.
  • Adasina Social CapitalcoreStrategic or Co-development Partner · 13 November 2024Adasina Social Capital launched Due Diligence 2.0 Commitment in 2020 and is transferring ownership to Rhia Ventures' Racial Equity Asset Lab (The REAL). Partnership aims to bring innovation to asset management industry standards for risk assessment.
  • FSGminorStrategic or Co-development Partner · 21 January 2020FSG is a social impact consulting firm that partnered with Rhia Ventures to publish Hidden Value: The Business Case for Reproductive Health, conducting research with PerryUndem surveying attitudes of 1,377 college-educated employed Americans.
  • New Markets Support Company (NMSC)minorStrategic or Co-development PartnerNMSC and Rhia Ventures co-hosted a program discussing NMSC's white paper on narrowing the Black-White health gap and opportunities for private investment to drive progress.
  • PropelevateminorStrategic or Co-development PartnerRhia Ventures partnered with Propelevate and Catalyst Global on a two-part virtual Masterclass for reproductive and maternal health companies looking to enter diverse global markets.
  • Catalyst GlobalminorStrategic or Co-development PartnerRhia Ventures partnered with Propelevate and Catalyst Global on masterclasses for reproductive and maternal health companies on scaling in diverse global contexts and navigating regulatory pathways.
  • HealthTech4Medicaid (HT4M)minorStrategic or Co-development PartnerRhia Ventures partnered with HealthTech4Medicaid and Manatt Health to equip early and growth-stage companies to expand participation in the Medicaid market for reproductive and maternal health equity.
  • Manatt HealthminorStrategic or Co-development PartnerPartnered with Rhia Ventures and HealthTech4Medicaid to provide learning collaborative for reproductive and maternal health innovators on Medicaid market entry and expansion.
  • Center for Democracy and Technology (CDT)minorStrategic or Co-development PartnerRhia Ventures hosted a virtual masterclass on Data Privacy for Reproductive Health with panelists from CDT, Euki, and aboboTech, providing practical strategies for funders and organizational leaders.
  • PerryUndemminorStrategic or Co-development PartnerResearch partner conducting surveys on attitudes and opinions of Americans regarding reproductive health care. Research undergirds Hidden Value report published by Rhia Ventures.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Rhia Ventures competitors and assessment

Company assessment

Direct peers

  • FSG: Social impact consulting firm that partnered with Rhia Ventures on the Hidden Value report. Operates at the intersection of impact strategy, foundation advising, and field-building in health equity.
  • Portfolia: Venture investing platform with a dedicated Femtech and women's health fund. Directly comparable as a women's health VC with similar stage and mission focus.
  • Tara Health Foundation: Co-founder and financial anchor of Rhia Ventures; a health-focused foundation that invests in reproductive and maternal health. Operates as a strategic philanthropic partner with overlapping program areas.
  • Foreground Capital: Independent venture firm spun out of RH Capital in September 2024, continuing to manage RH Capital Funds I and II and investing in early-stage women's health startups. Direct continuation of Rhia's VC investing activity.
  • SteelSky Ventures: Venture capital firm investing in women's health innovation, similar to RH Capital's strategy. Comparable early-stage investor targeting the same underserved women's health category.
  • Adasina Social Capital: Social justice investment advisor that originated the Due Diligence 2.0 Commitment and transferred ownership to Rhia Ventures in 2024. Operates in the adjacent racial and gender equity investing space and shares frameworks for inclusive due diligence.
  • Impact Frontiers: Collaborative of investors advancing impact management practice; co-delivers the Impact Measurement & Management for Health Equity cohort with Rhia Ventures and Duke CASE. Strongly overlapping audience of health-focused institutional investors.

Others

  • PerryUndem: Research partner that conducted the polling underpinning Rhia's Hidden Value report. Comparable as a reproductive health research and communications consultancy serving similar advocacy audiences.

Broad incumbents

  • Ms. Foundation for Women: Large women's rights foundation supporting reproductive justice and women's health movements. Operates broader than Rhia but is a comparable philanthropic and field-building player with overlapping grantee networks.

Emerging players

  • Avestria Ventures: Mission-driven fund focused on women's health and wellness startups. Smaller and earlier-stage than Rhia's VC operations, but addresses the same thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Rhia Ventures social profiles

Digital presence

Rhia Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rhia Ventures leadership team

Management profile

Number of profiles

Profiles6 records

Rhia Ventures subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Rhia Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rhia Ventures M&A and investment

M&A and investment

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rhia Ventures

What does Rhia Ventures do?

Rhia Ventures is a 501(c)(3) nonprofit that advances reproductive and maternal health equity through three activity pillars: systems change (proprietary equity frameworks such as HEART and The REAL), capital strategies (the RH Capital early-stage women's health venture fund), and advisory services for institutional investors, corporations, and entrepreneurs. The organization coordinates shareholder advocacy, operates educational learning cohorts, and accepts tax-deductible donations to support its mission.

Is Rhia Ventures a public or private company?

Rhia Ventures is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Rhia Ventures founded?

Rhia Ventures was founded in 2018. It employs 11 to 50 people.

Where is Rhia Ventures based?

Rhia Ventures is headquartered in Bellerose, United States, in the North America region.

How does Rhia Ventures make money?

Three revenue lines are on record. Donations and Charitable Contributions are the primary driver. The others are investment Returns (RH Capital) and advisory Services.

Who are Rhia Ventures's main competitors?

Direct peers on record are FSG, Portfolia, Tara Health Foundation, Foreground Capital, SteelSky Ventures, Adasina Social Capital and Impact Frontiers. PerryUndem is listed as an others. Ms. Foundation for Women is listed as a broad incumbent. Avestria Ventures is listed as an emerging player.

Does Rhia Ventures have an API?

No public API is recorded for Rhia Ventures.

What industry is Rhia Ventures in?

Rhia Ventures's product category is Reproductive Health Advocacy and Impact Investing. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of FSAAABAH, Philanthropy & Foundations Advisory (Donor-Advised Funds, Endowments). Its NAICS code is 525990 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SynBioBetaUSDA-Backed Loan Helps Plantible Foods Raise $35M to Scale Up Rubisco Protein FivefoldPlantible Foods raised $35M in USDA-backed loan and equity to quintuple its duckweed-derived Rubisco protein production. The funding includes $25M in debt from X-Caliber Rural Capital and $10M in equity, bringing total funding to $92M. The company will build up to 50 greenhouses to exceed 100,000 tonnes annually.FinSMEsPlantible Foods Raises $35M in FundingPlantible Foods raised $35M in combined debt and equity financing, with $25M in debt from X-Caliber Rural Capital and $10M in equity from RA Capital, Piva Capital, and existing investors. The company will use the funds to quintuple annual production capacity for its Rubi Protein at its Eldorado, Texas facility, enter new markets, and fulfill its customer pipeline.BioWorldExpedition Therapeutics navigates $115M series BExpedition Therapeutics raised $115 million in a series B financing led by General Atlantic. RA Capital, Vivo Capital, and existing investors including Sofinnova, Novo Holdings, and Sanofi Ventures participated. The round was announced on BioWorld Financings Respiratory Series B U.S.WebrazziBiyoteknoloji şirketi Expedition Therapeutics, 115 milyon dolar yatırım aldıExpedition Therapeutics raised $115 million in a B-series round led by General Atlantic. The funds will advance Phase 2 trials of EXPD-101, a DPP1 inhibitor for COPD, and expand its inflammatory disease portfolio. The company aims to develop oral small-molecule therapies for immune-related conditions.Venture Capital Access OnlineExpedition Therapeutics Announces Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPDExpedition Therapeutics closed an oversubscribed $115 million Series B financing led by General Atlantic, with participation from RA Capital, Vivo Capital, and existing investors. The funds will advance its lead DPP1 inhibitor EXPD-101 through Phase 2 clinical development, and the first patient has been dosed in the global Phase 2 COPD trial.FinSMEsExpedition Therapeutics Raises $115M in Series B FundingExpedition Therapeutics raised $115M in Series B financing led by General Atlantic. The funds will advance its lead DPP1 inhibitor EXPD-101 through Phase 2 clinical development and expand its pipeline for inflammatory diseases.MorningstarExpedition Therapeutics Announces Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPDExpedition Therapeutics closed an oversubscribed $115 million Series B financing led by General Atlantic, with participation from RA Capital, Vivo Capital, and existing investors. The funds will advance its lead DPP1 inhibitor EXPD-101 through Phase 2 clinical development, and the first patient has been dosed in the global Phase 2 COPD trial.STATRA Capital backs upstart rival to Ultragenyx and Ionis in rare brain diseaseRA Capital and other investors are backing Oak Hill Bio with $175 million to revive an experimental Angelman syndrome drug that Roche shelved. Oak Hill competes with Ultragenyx and Ionis, both running Phase 3 trials, with Ultragenyx expected to report results this year.BeBeezE' nata Cadenive, una nuova partnership di advisory internazionale fondata da 5 specialisti dell'm&a e corporate advisory - BeBeezCadenive, an international advisory partnership, was founded by five corporate finance and M&A firms from Poland, Germany, the Netherlands, the US, and Italy. The partners have completed 228 operations, including 80 cross-border deals, and the firm operates from nine locations across 20 countries.PR NewswireShareholders file numerous proposals addressing access to reproductive health care for 2023 proxy ballotsIn coordination with Rhia Ventures, institutional investors have filed 31 shareholder proposals addressing corporate reproductive health care policies for 2023 proxy ballots, more than doubling the previous year's activity. The proposals, organized into five categories, address corporate support for politicians restricting reproductive access (10), reproductive health data privacy (9), state policy risks (6), hospital abortion policies (2), health insurance coverage (3), and maternal health benefits (1). The filings build on a shareholder initiative launched in 2019 and follow the June 2022 US Supreme Court Dobbs decision that ended constitutional abortion protections.